HCA
HCA Healthcare, Inc. NYSE Listed Mar 10, 2011$375.17
-3.35%
vs $388.16
Mkt Cap $86.6B
52w Low $334.32
19.4% of range
52w High $545.13
50d MA $421.47
200d MA $460.57
P/E (TTM)
13.2x
EV/EBITDA
8.1x
P/B
—
Debt/Equity
-8.3x
ROE
-107.8%
P/FCF
11.3x
RSI (14)
48.30
ATR (14)
$10.82
Beta
1.37
50d MA
$421.47
200d MA
$460.57
Avg Volume
1.7M
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
One Park Plaza · Nashville, TN 37203 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 24, 2026 | TNS | 7.12 | 7.15 | +0.4% | 432.46 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% | — |
| Jan 27, 2026 | TNS | 7.46 | 8.01 | +7.4% | 505.84 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% | — |
| Oct 24, 2025 | TNS | 5.79 | 6.96 | +20.2% | 447.04 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% | — |
| Jul 25, 2025 | TNS | 6.29 | 6.84 | +8.7% | 334.32 | -0.7% | +1.9% | +1.2% | +3.1% | -0.3% | +0.8% | — |
| Apr 25, 2025 | TNS | 5.75 | 6.45 | +12.2% | 327.92 | -0.3% | +1.3% | +2.6% | +1.3% | -0.6% | +1.4% | — |
| Jan 24, 2025 | TNS | 6.13 | 6.22 | +1.5% | 313.07 | +1.0% | +6.0% | -1.0% | -0.3% | +2.1% | -1.4% | — |
| Oct 25, 2024 | TNS | 4.99 | 5.03 | +0.8% | 363.55 | -0.0% | -1.9% | +1.1% | +0.1% | -0.6% | -0.4% | — |
| Jul 23, 2024 | TNS | 4.85 | 5.53 | +14.0% | 340.17 | +1.2% | +1.1% | +2.6% | +0.6% | +1.1% | +0.7% | — |
| Apr 26, 2024 | TNS | 5.01 | 5.93 | +18.4% | 306.69 | +0.7% | +1.5% | -0.5% | -0.1% | -0.2% | -0.3% | — |
| Jan 30, 2024 | TNS | 5.06 | 5.93 | +17.2% | 301.59 | +0.6% | +1.1% | +3.2% | -1.7% | +0.4% | -1.2% | — |
| Oct 24, 2023 | TNS | 3.98 | 3.91 | -1.8% | 230.12 | -0.1% | -2.1% | -1.6% | +1.6% | -0.9% | +1.3% | — |
| Jul 27, 2023 | TNS | 4.22 | 4.29 | +1.7% | 276.32 | +0.7% | -1.1% | -0.2% | +0.4% | -1.6% | +0.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 | TD Cowen | Maintains | Buy → Buy | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | RBC Capital | Maintains | Outperform → Outperform | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | Barclays | Maintains | Overweight → Overweight | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | Truist | Maintains | Buy → Buy | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Apr 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $432.46 | $438.51 | +1.4% | +3.1% | -3.1% | +0.7% | -0.1% | -0.3% |
| Mar 10 | TD Cowen | Maintains | Buy → Buy | — | $545.13 | $543.89 | -0.2% | -1.4% | -0.1% | -0.9% | +0.1% | -1.5% |
| Feb 25 | Mizuho | Maintains | Outperform → Outperform | — | $526.52 | $527.00 | +0.1% | +2.7% | -2.7% | +0.7% | +0.6% | +1.7% |
| Feb 23 | UBS | Maintains | Buy → Buy | — | $532.30 | $535.00 | +0.5% | +0.7% | -1.8% | +2.7% | -2.7% | +0.7% |
| Feb 20 | JP Morgan | Maintains | Neutral → Neutral | — | $528.66 | $530.08 | +0.3% | +0.7% | +0.7% | -1.8% | +2.7% | -2.7% |
| Feb 6 | Argus | Maintains | Buy → Buy | — | $513.76 | $514.00 | +0.0% | -2.3% | -0.8% | +0.9% | +5.9% | +0.7% |
| Jan 30 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $482.53 | $481.18 | -0.3% | +1.2% | +1.8% | +0.5% | -1.1% | +4.1% |
| Jan 28 | Deutsche Bank | Maintains | Buy → Buy | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | Barclays | Maintains | Overweight → Overweight | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | UBS | Maintains | Buy → Buy | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | RBC Capital | Maintains | Outperform → Outperform | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | Truist | Maintains | Buy → Buy | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | Jefferies | Maintains | Buy → Buy | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 28 | Oppenheimer | Maintains | Outperform → Outperform | — | $505.84 | $499.60 | -1.2% | -2.9% | -1.8% | +1.2% | +1.8% | +0.5% |
| Jan 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $483.60 | $483.30 | -0.1% | -2.7% | +1.8% | -1.5% | +0.5% | +1.1% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $471.85 | $473.47 | +0.3% | -1.1% | +1.4% | -0.2% | +0.4% | +0.0% |
| Dec 15 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $484.77 | $474.93 | -2.0% | -1.6% | -1.5% | +0.4% | -1.1% | +1.4% |
| Nov 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $473.61 | $469.79 | -0.8% | -0.1% | -0.1% | +0.9% | +0.2% | +0.6% |
| Oct 28 | Jefferies | Maintains | Buy → Buy | — | $467.86 | $466.33 | -0.3% | -0.3% | +0.4% | -0.3% | -1.5% | +0.4% |
| Oct 27 | BofA Securities | Maintains | Neutral → Neutral | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | Goldman Sachs | Maintains | Buy → Buy | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | RBC Capital | Maintains | Outperform → Outperform | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | Mizuho | Maintains | Outperform → Outperform | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | TD Cowen | Maintains | Buy → Buy | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | UBS | Maintains | Buy → Buy | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | Truist | Maintains | Buy → Buy | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | Barclays | Maintains | Overweight → Overweight | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | Oppenheimer | Maintains | Outperform → Outperform | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $447.04 | $450.26 | +0.7% | +4.7% | -0.3% | +0.4% | -0.3% | -1.5% |
| Oct 17 | Mizuho | Maintains | Outperform → Outperform | — | $419.60 | $420.94 | +0.3% | +1.6% | +1.6% | -0.3% | +2.1% | -0.2% |
| Oct 14 | UBS | Maintains | Buy → Buy | — | $410.68 | $410.00 | -0.2% | +1.9% | +0.4% | -0.2% | +1.6% | +1.6% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $437.57 | $436.75 | -0.2% | -2.6% | -1.7% | -0.9% | -1.1% | +1.9% |
| Oct 7 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $433.55 | $435.00 | +0.3% | +0.9% | -2.6% | -1.7% | -0.9% | -1.1% |
| Oct 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $433.55 | $435.00 | +0.3% | +0.9% | -2.6% | -1.7% | -0.9% | -1.1% |
| Sep 18 | Barclays | Maintains | Overweight → Overweight | — | $399.39 | $396.70 | -0.7% | +0.4% | +0.3% | +1.2% | +0.5% | +1.8% |
| Sep 10 | BofA Securities | Maintains | Neutral → Neutral | — | $413.40 | $415.18 | +0.4% | -4.6% | +2.2% | +0.6% | -0.5% | -0.8% |
| Aug 26 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $402.77 | $401.09 | -0.4% | -0.2% | +0.8% | +0.6% | -0.8% | +0.5% |
| Aug 14 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $390.46 | $390.35 | -0.0% | +0.8% | +0.5% | -0.5% | +2.3% | +1.9% |
| Aug 14 | Baird | Maintains | Neutral → Neutral | — | $390.46 | $390.35 | -0.0% | +0.8% | +0.5% | -0.5% | +2.3% | +1.9% |
| Aug 4 | JP Morgan | Maintains | Neutral → Neutral | — | $356.97 | $356.73 | -0.1% | +1.7% | +0.2% | +0.6% | +2.0% | +2.2% |
No insider trades available.
8-K
HCA Healthcare, Inc. -- 8-K Filing
Jun 18
8-K · 8.01
!! High
HCA Healthcare, Inc. -- 8-K 8.01: Material Event / Announcement
HCA Healthcare is redeeming $2.5 billion in senior notes due mid-2026, allowing the company to refinance or delever its balance sheet ahead of maturity.
Apr 27
8-K · 8.01
!! High
HCA Healthcare, Inc. -- 8-K 8.01: Material Event / Announcement
HCA Healthcare's Board declared a $0.78 quarterly dividend per share, payable June 30, 2026 to shareholders of record June 16, 2026, demonstrating continued capital returns to investors.
Apr 24
8-K
HCA Healthcare, Inc. -- 8-K Filing
HCA Healthcare announced executive compensation adjustments for its President and CFO alongside its Chief Operating Officer, reflecting organizational leadership structure changes.
Feb 25
8-K · 5.02
!!! Very High
Norwegian Cruise Line Holdings Ltd. -- 8-K 5.02: Executive Change
Norwegian Cruise Line Holdings appointed John W. Chidsey as President, a leadership change that may signal strategic direction shifts for the cruise operator's operational and growth initiatives.
Feb 12
8-K · 5.02
!!! Very High
NCL CORP Ltd. -- 8-K 5.02: Executive Change
Norwegian Cruise Line Holdings appointed John W. Chidsey as President, signaling potential strategic leadership changes that investors should monitor for operational and financial direction shifts.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 10,178,362 | $4.8B | New | Mar 2026 |
| 2 | Sanders Capital, Llc | 8,957,145 | $4.2B | Reduced | Mar 2026 |
| 3 | First Eagle Investment Management, Llc | 6,509,140 | $3.1B | Reduced | Mar 2026 |
| 4 | Fmr Llc | 4,401,023 | $2.1B | Added | Mar 2026 |
| 5 | Morgan Stanley | 4,389,044 | $2.0B | Added | Dec 2025 |
| 6 | Vanguard Portfolio Management Llc | 2,757,779 | $1.3B | New | Mar 2026 |
| 7 | Jpmorgan Chase & Co | 2,461,975 | $1.2B | Added | Mar 2026 |
| 8 | Arrowstreet Capital, Limited Partnership | 2,165,258 | $1.0B | Reduced | Mar 2026 |
| 9 | Capital World Investors | 1,972,429 | $933M | Reduced | Mar 2026 |
| 10 | Northern Trust Corp | 1,752,127 | $829M | Reduced | Mar 2026 |
| 11 | Invesco Ltd. | 1,438,525 | $681M | Added | Mar 2026 |
| 12 | Nordea Investment Management Ab | 1,447,549 | $671M | Added | Mar 2026 |
| 13 | Barclays Plc | 1,248,315 | $591M | Reduced | Mar 2026 |
| 14 | Franklin Resources Inc | 1,216,596 | $576M | Reduced | Mar 2026 |
| 15 | Viking Global Investors | 1,075,133 | $509M | Added | Mar 2026 |
| 16 | Janus Henderson Group Plc | 1,017,441 | $481M | New | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 944,231 | $447M | Reduced | Mar 2026 |
| 18 | Royal Bank Of Canada | 886,505 | $420M | Reduced | Mar 2026 |
| 19 | Nuveen, Llc | 783,548 | $371M | Reduced | Mar 2026 |
| 20 | Life Cycle Investment Partners Ltd | 694,200 | $329M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$86.56B
Enterprise Value
$127.12B
P/E (TTM)
13.22x
Forward P/E
12.40x
PEG Ratio
0.56x
P/B
—
P/S
1.14x
P/FCF
11.25x
EV/EBITDA
8.15x
Shares Out
230.7M
Financials (TTM)
Revenue
$75.60B
Net Income
$6.78B
EBITDA
$15.60B
Free Cash Flow
$7.69B
Op Cash Flow
$12.64B
EPS Basic
$28.62
EPS Diluted
$28.38
EPS Forward
$30.24
Gross Margin
41.5%
Op Margin
15.8%
Net Margin
9.0%
Balance Sheet
Total Assets
$60.72B
Total Liab.
$63.49B
Total Equity
-$2.77B
Cash
$1.04B
LT Debt
$41.60B
Book Value/Sh
$-12.01
Debt/Equity
-8.33x
Current Ratio
0.83
Quick Ratio
0.73
Returns & Growth
ROE
-107.8%
ROA
11.1%
ROIC
18.5%
Rev Growth YoY
+7.1%
EPS Growth YoY
+28.5%
Price Returns
2W
-12.5%
1M
-12.9%
3M
-28.5%
6M
-25.5%
12M
-0.7%
Technicals
52W High
$545.13
52W Low
$334.32
50d MA
$421.47
200d MA
$460.57
RSI (14)
48.30
ATR (14)
$10.82
Beta
1.37
Avg Volume
1.7M
Dividends
Div Rate
$2.94
Div Yield
0.7%
Frequency
4
Ex-Div Date
Jun 16, 2026
Analyst Price Targets
Consensus
$527.45
High
$635.00
Low
$436.00
Median
$530.00
Data updated apr 25, 2026 1:06pm
· Source: financialmodelingprep.com